Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NHERF family PDZ scaffold protein 4 (NHERF4) is an epithelial-enriched scaffolding protein belonging to the NHERF family, characterized by multiple PDZ domains that enable protein–protein interactions, particularly at the apical membrane of epithelial cells[1][3]. NHERF4 is the most divergent member of the NHERF family and contains four PDZ domains, setting it apart structurally from NHERF1 and NHERF2, which have two PDZ domains each[1]. It organizes and regulates multiprotein complexes involved in epithelial cell polarity, ion transport (such as interaction with the type IIa sodium–phosphate co-transporter), and second messenger signaling[1][3]. Emerging studies suggest unique binding partners and subcellular localization for NHERF4 compared to other family members, but its precise biological functions require further investigation[1][3][5]. There are no established therapeutic drugs or mechanisms of action targeting NHERF4, nor are there recognized safety concerns or biomarkers. Diseases associated with NHERF4 mutations include motility-related diarrhea and lissencephaly 9[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NHERF family PDZ scaffold protein 4 (NHERF4).